人类莱姆病疫苗:在预防的道路上前进两步
Raphael Simon1, Erik Lamberth2, James H Stark3
1Bacterial Vaccines, Pfizer Vaccines, Pearl River, NY, USA.
Expert review of vaccines
|December 22, 2025
概括
莱姆病是一种传播的疾病,正在发生越来越多的发病率. 针对Borrelia burgdorferi外表面蛋白A的VLA15候选疫苗正处于人类使用的晚期临床开发阶段.
科学领域:
- * 传染病 传染病
- * 疫苗学 疫苗学 疫苗学
- * 医学昆虫学 医学昆虫学
背景情况:
- * 莱姆氏病是由传播的螺旋体Borrelia burgdorferi sensu lato (s.l. ) 的情况.
- *外表面蛋白A (OspA) 是防止传播的关键目标,因为对它的抗体可以阻止内的感染.
- *尽管之前基于OspA的疫苗取得了成功,但目前还没有针对人类的莱姆病疫苗.
研究的目的:
- * 审查莱姆病的历史,负担和载体生物学.
- *详细介绍了六价值OspA疫苗候选人VLA15.15的临床前和临床发展情况.
- * 评估VLA15作为对莱姆病的预防措施的潜力.
主要方法:
- *对莱姆病的历史回顾分析.
- * 对载体生物学和病原体特征的审查.
- *关于VLA15.5的临床前研究和临床试验数据的摘要.
主要成果:
- * 莱姆病的发病率和地理范围显著扩大.
- *VLA15的设计是为了准主导B. 布尔格多弗里 s.l. 北美和欧洲的基因种.
- *VLA15是临床开发中最先进的莱姆病候选疫苗.
结论:
- 莱姆氏病是一个日益严重的公共卫生问题.
- *VLA15代表了莱姆病预防的有希望的战略.
- *如果被证明是安全和有效的,VLA15可能成为一个重要的预防工具.
相关概念视频
Cancer Vaccines
929
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
929
Vaccinations
51.1K
Overview
51.1K
Microorganisms in Medicine and Therapeutics
914
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
914


